title: Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease.
authors.affiliation: INSERM U291, Montpellier, France.
authors.forename: B
authors.initials: B
authors.lastname: Klein
authors.forename: X G
authors.initials: XG
authors.lastname: Zhang
authors.forename: M
authors.initials: M
authors.lastname: Jourdan
authors.forename: M
authors.initials: M
authors.lastname: Portier
authors.forename: R
authors.initials: R
authors.lastname: Bataille
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D002455:Cell Division; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000502:physiology; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D007377:Interleukin-3 / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology*; D009101:Multiple Myeloma / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D007377:Interleukin-3; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007372:Interferons